Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in Chronic Neuropathic Pain
NCT01743976Phase 4Terminated
- Sponsor
- Wake Forest University
- Start
- Dec 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in neuropathic pain comparing Donepezil with Placebo (2 arms). Primary endpoint: McGill Short Form Pain Questionnaire Visual Analog Scale Pain Intensity at Week 10. Started Dec 2012; status: terminated.
02
Drugs
donepezil
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT01743976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01743976.